About: RMSDs of complex GSK-3/compounds (31, a1) for 100 ns MD simulations. With compound 31 and a1 in red and black is GSK3
In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation 2
Details.